Phase 2 clinical trial data for retatrutide, published in the New England Journal of Medicine in 2023, demonstrated mean weight reductions of approximately 1724% of body weight over 48 weeks, depending on dose results that exceed those seen with currently licensed agents in comparable timeframes
GH release was a single episode peaking near 0.67 h and declining to negligible concentrations at every dose [5]
At Pure Med Spa Chicago , we specialize in personalized weight loss treatments, including GLP-1 medications
Always consult a qualified prescriber before starting any prescription weight loss treatment
Also, be sure to understand your insurance plans coverage criteria and whether you meet them
Because the signal originates at the receptor level, it bypasses hypothalamic and pituitary regulatory layers